Thye Dirk Insider Trades

Insider Trading History

Track insider trading activity for Thye Dirk. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Quince Therapeutics
Quince Therapeutics QNCX
CEO And CMO
Holding Value $1.03M 1,000,000 shares
Last Trade
Jan 23, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.08M 1,000,000 shares
$3.08
$1.03
Quince Therapeutics
Quince Therapeutics QNCX
CEO And CMO
Holding Value $762k 739,885 shares
Last Trade
Dec 10, 2025 Purchase (Gift)Shares transferred as a gift rather than bought or sold for cash.
$2.96M 739,885 shares
$4.00
$1.03
Quince Therapeutics
Quince Therapeutics QNCX
CEO And CMO
Holding Value $263k 255,000 shares
Last Trade
Dec 10, 2025 Sale (Gift)Shares transferred as a gift rather than bought or sold for cash.
$2.96M 739,885 shares
$4.00
$1.03
Quince Therapeutics
Quince Therapeutics QNCX
CEO And CMO
Holding Value $1.02M 994,885 shares
Last Trade
Jun 18, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$411k 301,888 shares
$1.36
$1.03
Quince Therapeutics
Quince Therapeutics QNCX
CEO AND CHIEF MEDICAL OFFICER
Holding Value $1.24M 1,200,000 shares
Last Trade
Jan 28, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.92M 1,200,000 shares
$1.60
$1.03
Quince Therapeutics
Quince Therapeutics QNCX
CEO AND CHIEF MEDICAL OFFICER
Holding Value $869k 843,941 shares
Last Trade
Aug 30, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$53.9k 77,000 shares
$0.70
$1.03
Quince Therapeutics
Quince Therapeutics QNCX
CEO AND CHIEF MEDICAL OFFICER
Holding Value $790k 766,941 shares
Last Trade
Aug 29, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$53.5k 77,500 shares
$0.69
$1.03
Quince Therapeutics
Quince Therapeutics QNCX
CEO AND CHIEF MEDICAL OFFICER
Holding Value $1.55M 1,500,000 shares
Last Trade
Feb 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.97M 1,500,000 shares
$1.31
$1.03
Quince Therapeutics
Quince Therapeutics QNCX
CHIEF EXECUTIVE OFFICER
Holding Value $464k 450,001 shares
Last Trade
Jan 16, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$330k 240,530 shares
$1.37
$1.03
Quince Therapeutics
Quince Therapeutics QNCX
CHIEF EXECUTIVE OFFICER
Holding Value $710k 689,441 shares
Last Trade
Jan 16, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$330k 240,530 shares
$1.37
$1.03
Quince Therapeutics
Quince Therapeutics QNCX
Chief Executive Officer
Holding Value $462k 448,911 shares
Last Trade
Aug 10, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$111k 88,000 shares
$1.26
$1.03
Quince Therapeutics
Quince Therapeutics QNCX
Chief Executive Officer
Holding Value $372k 360,911 shares
Last Trade
Aug 08, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$99.2k 80,000 shares
$1.24
$1.03
Quince Therapeutics
Quince Therapeutics QNCX
Chief Executive Officer
Holding Value $618k 600,000 shares
Last Trade
Feb 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$564k 600,000 shares
$0.94
$1.03
Cortexyme
Cortexyme CRTX
Chief Executive Officer
Holding Value $126k 64,589 shares
Last Trade
May 19, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$213k 64,589 shares
$3.30
$1.95
Cortexyme
Cortexyme CRTX
Chief Executive Officer
Holding Value $548k 280,911 shares
Last Trade
May 19, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$714k 216,322 shares
$3.30
$1.95
Cidara Therapeutics
Cidara Therapeutics CDTX
Chief Medical Officer
Holding Value $17.7M 80,000 shares
Last Trade
Mar 16, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$15.8M 80,000 shares
$197.80
$221.38
Cidara Therapeutics
Cidara Therapeutics CDTX
Chief Medical Officer
Holding Value $0 0 shares
Last Trade
Feb 19, 2015 Sale
No data
No data
$221.38

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up